FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3159501004> ?p ?o ?g. }

• W3159501004 abstract "The coronavirus disease (COVID-19) has spread worldwide since early 2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines for the Management of Sepsis and Septic Shock (J-SSCG) 2020 Special Committee created the Japanese rapid/living recommendations on drug management for COVID-19 using the experience of creating the J-SSCGs. The Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) approach was used to determine the certainty of the evidence and strength of the recommendations. The first edition of this guideline was released on 9 September, 2020, and this document is the revised edition (version 3.1) (released 30 March, 2021). Clinical questions (CQs) were set for the following seven drugs: favipiravir (CQ1), remdesivir (CQ2), hydroxychloroquine (CQ3), corticosteroids (CQ4), tocilizumab (CQ5), ciclesonide (CQ6), and anticoagulants (CQ7). Favipiravir is recommended for patients with mild COVID-19 not requiring supplemental oxygen (GRADE 2C); remdesivir for moderate COVID-19 patients requiring supplemental oxygen/hospitalization (GRADE 2B). Hydroxychloroquine is not recommended for all COVID-19 patients (GRADE 1B). Corticosteroids are recommended for moderate COVID-19 patients requiring supplemental oxygen/hospitalization (GRADE 1B) and severe COVID-19 patients requiring ventilator management/intensive care (GRADE 1A); however, their use is not recommended for mild COVID-19 patients not requiring supplemental oxygen (GRADE 1B). Tocilizumab is recommended for moderate COVID-19 patients requiring supplemental oxygen/hospitalization (GRADE 2B). Anticoagulant therapy is recommended for moderate COVID-19 patients requiring supplemental oxygen/hospitalization and severe COVID-19 patients requiring ventilator management/intensive care (GRADE 2C). We hope that these clinical practice guidelines will aid medical professionals involved in the care of COVID-19 patients." @default.
• W3159501004 created "2021-05-10" @default.
• W3159501004 creator A5003857215 @default.
• W3159501004 creator A5004342411 @default.
• W3159501004 creator A5012888329 @default.
• W3159501004 creator A5013726912 @default.
• W3159501004 creator A5014765734 @default.
• W3159501004 creator A5016846250 @default.
• W3159501004 creator A5018631757 @default.
• W3159501004 creator A5024738150 @default.
• W3159501004 creator A5032342136 @default.
• W3159501004 creator A5041347997 @default.
• W3159501004 creator A5041519244 @default.
• W3159501004 creator A5046816913 @default.
• W3159501004 creator A5050533134 @default.
• W3159501004 creator A5052226149 @default.
• W3159501004 creator A5053891527 @default.
• W3159501004 creator A5061102458 @default.
• W3159501004 creator A5066466748 @default.
• W3159501004 creator A5068933649 @default.
• W3159501004 creator A5073916680 @default.
• W3159501004 creator A5079036022 @default.
• W3159501004 creator A5081009970 @default.
• W3159501004 creator A5081383438 @default.
• W3159501004 creator A5087956208 @default.
• W3159501004 date "2021-01-01" @default.
• W3159501004 modified "2023-10-03" @default.
• W3159501004 title "Japanese rapid/living recommendations on drug management for COVID‐19" @default.
• W3159501004 cites W2531269403 @default.
• W3159501004 cites W2884033130 @default.
• W3159501004 cites W2952092758 @default.
• W3159501004 cites W2970684805 @default.
• W3159501004 cites W3018023298 @default.
• W3159501004 cites W3021954309 @default.
• W3159501004 cites W3025795175 @default.
• W3159501004 cites W3027630905 @default.
• W3159501004 cites W3028989873 @default.
• W3159501004 cites W3033189130 @default.
• W3159501004 cites W3040442079 @default.
• W3159501004 cites W3041384178 @default.
• W3159501004 cites W3043308024 @default.
• W3159501004 cites W3044118599 @default.
• W3159501004 cites W3044913236 @default.
• W3159501004 cites W3048510827 @default.
• W3159501004 cites W3049244841 @default.
• W3159501004 cites W3049278054 @default.
• W3159501004 cites W3080671425 @default.
• W3159501004 cites W3080718665 @default.
• W3159501004 cites W3081506797 @default.
• W3159501004 cites W3081515108 @default.
• W3159501004 cites W3081721922 @default.
• W3159501004 cites W3081877184 @default.
• W3159501004 cites W3082108964 @default.
• W3159501004 cites W3087060799 @default.
• W3159501004 cites W3087214787 @default.
• W3159501004 cites W3089370525 @default.
• W3159501004 cites W3091868035 @default.
• W3159501004 cites W3092231621 @default.
• W3159501004 cites W3092252175 @default.
• W3159501004 cites W3092712522 @default.
• W3159501004 cites W3092984699 @default.
• W3159501004 cites W3093604087 @default.
• W3159501004 cites W3093837118 @default.
• W3159501004 cites W3094609299 @default.
• W3159501004 cites W3098266159 @default.
• W3159501004 cites W3102015759 @default.
• W3159501004 cites W3102453076 @default.
• W3159501004 cites W3103789002 @default.
• W3159501004 cites W3110466220 @default.
• W3159501004 cites W3110844195 @default.
• W3159501004 cites W3110955805 @default.
• W3159501004 cites W3129869280 @default.
• W3159501004 cites W3130126061 @default.
• W3159501004 cites W4210642183 @default.
• W3159501004 doi "https://doi.org/10.1002/ams2.664" @default.
• W3159501004 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8209876" @default.
• W3159501004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34178358" @default.
• W3159501004 hasPublicationYear "2021" @default.
• W3159501004 type Work @default.
• W3159501004 sameAs 3159501004 @default.
• W3159501004 citedByCount "9" @default.
• W3159501004 countsByYear W31595010042021 @default.
• W3159501004 countsByYear W31595010042022 @default.
• W3159501004 countsByYear W31595010042023 @default.
• W3159501004 crossrefType "journal-article" @default.
• W3159501004 hasAuthorship W3159501004A5003857215 @default.
• W3159501004 hasAuthorship W3159501004A5004342411 @default.
• W3159501004 hasAuthorship W3159501004A5012888329 @default.
• W3159501004 hasAuthorship W3159501004A5013726912 @default.
• W3159501004 hasAuthorship W3159501004A5014765734 @default.
• W3159501004 hasAuthorship W3159501004A5016846250 @default.
• W3159501004 hasAuthorship W3159501004A5018631757 @default.
• W3159501004 hasAuthorship W3159501004A5024738150 @default.
• W3159501004 hasAuthorship W3159501004A5032342136 @default.
• W3159501004 hasAuthorship W3159501004A5041347997 @default.
• W3159501004 hasAuthorship W3159501004A5041519244 @default.
• W3159501004 hasAuthorship W3159501004A5046816913 @default.
• W3159501004 hasAuthorship W3159501004A5050533134 @default.
• W3159501004 hasAuthorship W3159501004A5052226149 @default.
• W3159501004 hasAuthorship W3159501004A5053891527 @default.

• next